True histiocytic and accessory dendritic cell tumours are very rare, constituting less than 1% of tumours presenting in lymph nodes. Many tumours previously thought to be of histiocytic or reticulum cells origin have been re-assigned1:
Original terminology |
Current terminology |
Histiocytic lymphoma, nodular and diffuse |
DLBCL, follicular lymphoma, grade 3, peripheral T-cell lymphoma |
Histiocytic medullary reticulosis / malignant histiocytosis |
Haemophagocytic syndrome |
Malignant histiocytosis |
|
Regressing atypical histiocytosis |
|
Malignant histiocytosis of the intestine |
|
Histiocytic cytophagic panniculitis |
Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome |
The following five antibodies appear to be able to reliably distinguish between the histiocytic and accessory dendritic cell neoplasms in most cases, with additional morphological and ultrastructural features resolving the cases which depart from the usual immunophenotype2.
|
lysozyme |
||||
positive |
positive |
negative |
variable |
negative |
|
positive |
variable |
positive |
positive |
negative |
|
variable |
variable |
negative |
positive |
negative |
|
variable |
negative |
negative |
negative |
positive |
|
For further details, see specific tumours. Immunoglobulin T cell antigen-receptor genes should be of germline configuration.
There is a case report of a tumour showing hybrid features of follicular dendritic cell tumour and Interdigitating dendritic cell tumour3.
Usually aggressive neoplasms with a poor prognoses.
1World Health Organization Classification of Tumours, Tumours of the haematopoietic and lymphoid tissues, IARC Press 2001.
This page last revised 13.5.2003.
©SMUHT/PW Bishop